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The delivery of intracellular substrates such as misfolded
proteins and damaged organelles from the cytosol to the
lysosome for degradation is crucial for cell survival.
Multiple transport pathways including bulk autophagy
(microautophagy and macroautophagy) and chaperone-
mediated autophagy (CMA) have been identified to effi-
ciently facilitate this transit of macromolecules from the
cytoplasm to acidic vacuolar organelles. While autophagy
plays a role in the general housekeeping of cells, it also
functions in more specialized processes such as develop-
ment and differentiation, responses to physiological
stress and immunity. The presentation of both exo-
genous and endogenous antigens (Ag) bymajor histocom-
patibility complex (MHC) class II molecules to CD41
T lymphocytes is critical for the induction of tolerance
to self Ag aswell as the development of immunity against
intracellular pathogens and tumors. Here, we discuss the
class II-mediated presentation of several endogenous Ag,
dependent on either macroautophagy or CMA for their
transport from the cytosol to endosomal/lysosomal com-
partments. Thus, the various pathways of autophagy as
routes of cytoplasmic Ag delivery to lysosomes have
significant implications for the MHC class II-mediated
immune response to intracellular pathogens and cancer.
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The continuous turnover of intracellular proteins is critical
for the maintenance of cellular homeostasis. Cells have
multiple mechanisms to achieve this, including the ubi-
quitin/proteasome system (1) as well as lysosomal degra-
dation pathways including autophagy (2). Autophagy is
a constitutively active process but is upregulated as
a mechanism to salvage amino acids during periods of
cellular stress such as nutrient deprivation. These path-
ways of lysosomal degradation have physiological rele-
vance with respect to several cellular processes including
immune recognition and responsiveness. This article re-
views the pathways for cytosol to lysosome transport and
their role in immunity and host defense.
MHC class I and class II molecules on antigen-presenting
cells (APC) selectively acquire peptides from self and
foreign Ag for presentation to CD8þ and CD4þ T lympho-
cytes, respectively. The spectrum of peptides displayed by
class I and class II proteins is essential for self-tolerance
as well as the development of immunity against invasive
pathogens and tumors. Traditionally, immunologists
believed that class I and class II molecules obtained their
ligands from distinct subcellular pools of Ag. In this model,
endogenous Ag processed in the cytosol gave rise to
peptides for MHC class I presentation to CD8þ T cells
while engulfed exogenous Ag degraded in endosomes and
lysosomes were destined for MHC class II presentation to
CD4þ T lymphocytes. While this paradigm remains true,
alternative pathways for delivering exogenous Ag to MHC
class I molecules have recently been characterized (3).
Similarly, biochemical and functional studies indicate that
MHC class II molecules also display peptides from cyto-
plasmic and nuclear proteins for CD4þ T cell recognition
with implications for viral, tumor and autoimmunity (4).
Here, we discuss several pathways of cytosol to lysosome
transport of potential importance to the development of
host immune responses and specifically MHC class II-
mediated Ag presentation.
The MHC Class II Ag Presentation Pathway
MHC class II molecules present antigenic peptides derived
from exogenous as well as cytoplasmic proteins to CD4þ
T cells (4,5). MHC class II proteins are constitutively ex-
pressed on the surface of a number of professional APC
such as dendritic cells (DC), B cells and macrophages as
well as both cortical and medullary thymic epithelial cells.
Treatment with an inflammatory signal such as interferon-
gamma (IFN-g) can induce MHC class II expression on the
surface of non-professional APC such as endothelial cells,
fibroblasts, epithelial cells and many tumors. MHC class II
complexes consist of a and b subunits, which are first
assembled in the endoplasmic reticulum (ER) with the
chaperone molecule invariant chain (Ii) (6) (Figure 1). The
precise role of Ii early in the transport pathway has been
controversial with evidence, suggesting that Ii protects the
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MHC class II molecule from associating with unfolded
proteins in the ER (7) as well as from improper peptide
loading as the complex traffics from the ER through the
trans Golgi network (TGN) (8). The cytoplasmic tail of Ii
contains a leucine-basedmotif that facilitates the sorting of
MHC class II–Ii complexes through clathrin adaptor pro-
teins found on clathrin-coated vesicles in the TGN (9). From
the TGN, MHC class II–Ii complexes enter the endocytic
pathway in order to interact with Ag (10). A portion of these
complexes traffics directly from the TGN to endosomes
and then to late endosomes and prelysosomes. Alter-
natively, a pool of newly synthesized MHC class II–Ii
complexes egresses to the cell surface through the
constitutive secretory pathway and then is rapidly internal-
ized at the plasma membrane, thus gaining access to the
endocytic pathway. Ii release fromMHC class II is required
for class II function and binding of antigenic peptides of
12–25 amino acids in length (6). Exogenous Ag delivered
into the endocytic network through receptor-mediated or
fluid-phase endocytosis are exposed to acidic proteases
and denaturing reactions, yielding peptide ligands for class
II molecules within the endosomal network (11). The
binding of these peptides to class II molecules is facilitated
by an editor protein, HLA-DM (12–14), which resides in
a highly specialized organelle resembling a late endosome
known as the MHC class II compartment (MIIC) (15).
Recent studies have begun to reveal how peptides from
cytoplasmic proteins might also access class II molecules
within the endocytic pathway (16,17). Resultant peptide–
MHC class II complexes are ultimately trafficked to the cell
surface for immune surveillance by CD4þ T cells.
Pathways of Lysosomal Proteolysis
Of critical importance in Ag presentation by MHC class II
molecules is the degradation of proteins to antigenic
peptides. To achieve this, APC exploit the intracellular
proteolytic machinery common to most cells. Short-lived
cytoplasmic Ag may be degraded by cytosolic proteases
such as the proteasome and calpain. Proteolysis of cyto-
plasmic Ag, like exogenous Ag, may also occur in lyso-
somes, which are morphologically heterogenous with
a low pH environment conducive to protein unfolding and
the activation of acid-dependent hydrolases (18). Protein
transit from the cytosol to lysosomes, also known as
autophagy, typically leads to substrate degradation (2).
Autophagy occurs through three distinct mechanisms:
microautophagy, macroautophagy and CMA (Figure 1).
In microautophagy, small portions of the cytosol are
Figure 1: Pathways for MHC class II presentation of exogenous and endogenous Ag. Left: exogenous proteins are endocytosed and
degraded by acidic proteases resident within endosomes and lysosomes. MHC class II molecules are assembled in the ER with the
chaperone protein Ii, which targets these complexes to the endosomal pathway. Nascent as well as recycling MHC class II molecules
acquire peptide ligands within endosomal compartments and then egress to the cell surface for presentation to CD4þ T cells. Right:
endogenous proteins may be degraded into antigenic peptides by the proteasome and transported into lysosomes through multiple
pathways such as microautophagy, macroautophagy and CMA. In microautophagy, portions of the cytosol are continuously internalized
through lysosomal invaginations. In macroautophagy, the cytoplasm is sequestered into double-membraned structures known as
autophagosomes, which fuse with lysosomes. In CMA, specific cytosolic proteins are transported into lysosomes through a molecular
chaperone/receptor complex composed of hsc70 and LAMP-2A. These antigenic fragments intersect with MHC class II molecules in
a mature endosomal compartment known as the MIIC prior to presentation to CD4þ T cells.
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internalized through lysosomal invaginations, and pro-
teins are continuously degraded in the lumen of this
organelle even under resting conditions (19). Microau-
tophagy is upregulated under conditions of cellular stress
such as starvation, but studies of this pathway have been
limited to yeast and cell-free systems so little is known
about its role in mammalian cells (20,21). Macroautoph-
agy is also a constitutively active process in cells for
the degradation of long-lived proteins and organelles (2),
and during short periods of nutrient deprivation, this
pathway is induced as a mechanism to salvage amino
acids. In macroautophagy, the cytoplasm is sequestered
into double-membraned structures known as autophago-
somes, which fuse with lysosomes forming an autolyso-
some. Following fusion, the vacuolar material is degraded
and the products are recycled back into the cytosol.
Because these pathways show no specificity or selectivity
in terms of the material sequestered, they have been
termed bulk autophagy.
During periods of prolonged cellular stress, bulk autophagy
declines and the process of CMA is instead activated.
In CMA, specific cytosolic proteins displaying homologous
pentapeptide motifs bind to a molecular chaperone com-
plex composed of multiple heat-shock proteins including
the heat-shock 70-kDa protein (hsc70) (reviewed in 22).
This molecular chaperone complex transports the sub-
strate protein to the lysosomal membrane, where it
associates with an isoform of the lysosome-associated
membrane protein-2, LAMP-2A, which functions as part of
the lysosomal receptor for CMA. The cytoplasmic domain
of LAMP-2A serves as a potential docking site for the
molecular chaperone–substrate complex, and these chap-
erones likely unfold substrate proteins, enabling them to
bind and translocate across the lysosomal membrane.
Lysosomal hsc70 assists with the transport of the proteins
into the organelle lumen, where these molecules are
degraded by mature acidic proteases.
Cytosol to Lysosome Transport of Ag in APC
While bulk autophagy and CMA are essential for general
protein turnover in most cells under normal conditions and
periods of cellular stress, respectively, these pathways
may also play a more specialized role in APC such as DC, B
cells and macrophages. For example, the multiple forms of
autophagy could function as routes for antigenic proteins
located in the cytosol to reach the lysosome for processing
into peptides prior to binding to MHC class II molecules in
the MIIC compartment (Figure 1). Blocking these path-
ways of cytoplasmic to lysosomal transport may result
in a reduction in the presentation of endogenous Ag by
MHC class II molecules to CD4þ T lymphocytes. Here, we
summarize the recent evidence linking macroautophagy
and CMA to the processing and class II-restricted pre-
sentation of cytosolic and nuclear Ag in APC.
Macroautophagy
Macroautophagy appears to play an essential role during
development and oncogenesis as well as in response to
physiological stress (23), but its role in immunological
processes, in particular MHC class II-restricted Ag presen-
tation, has only been recently studied. Dengjel et al.
employed mass spectrometry to examine how the induc-
tion of autophagy alters the complex spectrum of peptides
displayed byMHC class II molecules (24). Following serum
starvation of human B-lymphoblastoid cell lines (B-LCL) to
induce autophagy for different time periods, the authors
observed an increase in those MHC class II-associated
peptides derived from intracellular proteins. They also
demonstrated that the induction of autophagy by starva-
tion alters the balance of active proteases such as the
cathepsins within lysosomes, suggesting that starvation-
induced autophagy may alter the Ag processing machinery
for MHC class II-mediated presentation.
Macroautophagy is a highly regulated process in both
yeast and mammalian cells, and the nutrient-sensing
target of rapamycin (Tor) molecule plays a key role in
regulating macroautophagy (19). Excess nutrients or
growth factors activate phosphatidylinositol 3-kinase
(PI3K), resulting in the downstream activation of Tor and
a decrease in macroautophagy. Macroautophagy is sensi-
tive to the PI3K inhibitors 3-methyladenine (3-MA) (25) and
wortmannin (26), and several investigators have used
these compounds to examine how inhibiting autophagy
affects MHC class II Ag presentation. Nimmerjahn et al.
demonstrated that the treatment of human B cells with
3-MA or wortmannin completely abrogated the MHC class
II-restricted presentation of the transfected cytosolic bac-
terial protein neomycin phosphotransferase II (NeoR) (27).
Interestingly, the authors also showed that the generation
of the NeoR epitope is dependent on lysosomal acidic
proteases rather than cytosolic enzymes, suggesting that
this Ag expressed in the cytoplasm must gain access to
lysosomal compartments for proper epitope formation. A
more recent report showed that the MHC class II-mediated
presentation of mucin-1 (MUC-1) peptides in DC trans-
fected with MUC-1 RNA was also sensitive to both 3-MA
and wortmannin (28). However, the investigators found
that the generation of the MUC-1 epitope was dependent
on processing in both the cytosol and the lysosomal
compartments, suggesting that the MUC-1 Ag is first
partially degraded in the cytosol and then transported
through macroautophagy to the lysosome for further
processing.
Nuclear proteins, like cytosolic proteins, may also be
sources of antigenic peptides for MHC class II-restricted
CD4þ T lymphocytes. Paludan et al. recently showed
that the inhibition of lysosomal acidification by chloroquine
in Epstein–Barr virus (EBV)-transformed human B-LCL
resulted in the accumulation of the EBV nuclear antigen
1 (EBNA 1) in intracellular vesicles positive for the
lysosome-associated membrane protein-1 (LAMP-1) and
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monodansylcadaverine (29), a fluorescent marker specific
for autophagosomes (30). Treatment of the B-LCL with
3-MA reduced the MHC class II-restricted presentation
of EBNA 1, suggesting that macroautophagy may be the
mechanism by which this nuclear Ag gains access to
lysosomes for epitope processing. Duringmacroautophagy,
autophagosome initiation and formation require several
autophagy-related gene (Atg) products, first identified
and characterized in yeast (19,31). Paludan et al. further
demonstrated that silencing the essential autophagy gene
Atg12 with small interfering RNA also diminished the
activation of EBNA 1-specific CD4þ T cells (29). Similar to
the generation of the NeoR epitope, the processing of the
EBNA 1 epitope for MHC class II presentation may depend
on the activation of acid-dependent hydrolases resident in
lysosomes rather than cytosolic proteases such as the
proteasome. In the case of the long-lived protein EBNA 1,
autophagy may serve as the main degradative pathway
whereas the proteasome is more likely responsible for the
degradation of short-lived proteins.
While it appears that macroautophagy regulates the lyso-
somal processing of several endogenous Ag, the question
remains how the antigenic peptides generated in lyso-
somes gain access to the MIIC compartments in APC.
Previous electron microscopy studies had shown that the
endocytic pathway intersects the autophagy pathway (32),
and it is possible that MHC class II-positive endosomes
might converge with autophagosomes in APC. Recently,
Schmid et al. reported that in APC such as B cells and DC,
autophagosomes are constitutively formed and that these
vacuolar-like structures continuously fuse with MIIC (17).
In these studies, the authors showed that the autophago-
some marker LC3 colocalizes with resident proteins of the
MIIC such as MHC class II molecules, the chaperone HLA-
DM and the lysosome membrane protein LAMP-2. Fur-
thermore, when the cytosolic Ag influenza matrix protein-1
(MP-1) was directly targeted to autophagosomes by fusion
with LC3, an increase in the MHC class II-mediated pre-
sentation of MP-1 to CD4þ T cells was observed. These
results suggest that macroautophagy is an effective route
for delivery of endogenous Ag to MHC class II molecules
for the activation of CD4þ T lymphocytes.
The MHC class II-mediated presentation of several cyto-
plasmic Ag requires the induction of macroautophagy and
subsequent lysosomal processing, yet the presentation of
other cytosolic Ag by MHC class II molecules is insensitive
to 3-MA treatment and less dependent on the activity of
lysosomal proteases. For example, treatment of human B
cells expressing the cytoplasmic autoantigen glutamate
decarboxylase (GAD) with proteasome inhibitors or calpain
selectively blocked the MHC class II-restricted presenta-
tion of this Ag (33). Conversely, cytoplasmic GAD pre-
sentation is only slightly reduced in B cells treated with
chloroquine or lysosomal protease inhibitors, suggesting
that processing of GAD in the cytosol before transport to
the MIIC is key for the class II-mediated presentation of
this Ag. Furthermore, the treatment of human B cells with
3-MA has no significant effect on the MHC class II-
restricted presentation of cytoplasmic GAD or another
cytosolic autoantigen, SMA, a mutant form of the human
immunoglobulin kappa light chain (D. Zhou and J. S. B.,
unpublished data). For these cytoplasmic Ag, macroau-
tophagymay not be the primary route of transport from the
cytosol. Similarly, the MHC class II-restricted presentation
of the I-Ea protein expressed in the cytosol was dependent
on a functional proteasome (34) but insensitive to 3-MA
treatment (35). In contrast, tumor cells transfected with
hen egg lysozyme (HEL) in the cytoplasm do not require
the proteasome or macroautophagy for the MHC class II-
mediated presentation of the HEL epitope (36). Lastly,
Taylor et al. recently showed no inhibition of the MHC
class II-restricted presentation of two EBV nuclear Ag,
EBNA 2 and EBNA 3C following 3-MA treatment of B-LCL
(37). Instead, the authors demonstrated that these Ag gain
access to the MHC class II pathway through intercellular
Ag transfer. Whether intact Ag or antigenic fragments
complexed with other proteins or within exosomes are
transferred is unknown, but Ag processing by lysosomal
proteases in the recipient cell is required for theMHC class
II-restricted presentation of these EBV Ag. Overall, these
findings indicate that macroautophagy may be an import-
ant mechanism for the processing of some cytoplasmic
Ag and their delivery to MHC class II molecules. Con-
versely, for those cytoplasmic Ag dependent on the
activity of cytosolic proteases for their processing, macro-
autophagy may play a less significant role in MHC class
II-mediated presentation.
Chaperone-mediated autophagy
Other mechanisms of cytosol to lysosome transport must
exist for those cytoplasmic Ag which do not utilize bulk
autophagy as the pathway to reach the lysosome. Previous
studies have shown that components of the MHC class I
Ag presentation pathway such as the proteasome are
important in the processing of cytoplasmic Ag (33,34).
Thus, the TAP heterodimer, which delivers the majority of
MHC class I peptides from the cytosol to the ER, might
play an important role in the transport of cytoplasmic Ag
fragments into endosomal or lysosomal compartments.
Recently, the proteasome- and TAP-dependent generation
of two MHC class II-restricted epitopes encoded within
two transmembrane glycoproteins of infectious influenza
virus was reported in both murine B cells and DC (38).
These results differ from several reports from a number of
laboratories, suggesting that TAP plays no role in the
presentation of cytoplasmic Ag to MHC class II molecules
(16,27,33,35,36,39). To explain the discrepancy in these
results, the authors suggest that in cells with more perme-
able endosomal membranes such as DC, cytosolic Ag
might have more access to this TAP-dependent pathway
than in B cells and fibroblasts containing more rigid endo-
somal membranes. Further studies regarding this transport
in specialized immune cells such as DC are clearly needed.
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Another possible mechanism for the transfer of cytosolic
Ag to endosomal or lysosomal compartments for process-
ing and binding to MHC class II molecules is CMA.
Recently, our laboratory demonstrated a role for CMA in
regulating cytoplasmic Ag presentation by MHC class II
molecules bymodulating the cellular levels of two compon-
ents of the CMA pathway, LAMP-2A and hsc70, in human
B cells expressing cytoplasmic Ag GAD and SMA (16).
Expression of antisense complementary DNA (cDNA) for
LAMP-2 reduced the MHC class II-restricted presentation
of GAD, while overexpression of the LAMP-2A isoform
resulted in an increased presentation of epitopes from
both GAD and SMA. Alternative splicing of the LAMP-2
gene gives rise to three isoforms in humans, termed
LAMP-2A, 2B and 2C (40) (D. Zhou and J. S. B., unpub-
lished data). While LAMP-2A and 2B are ubiquitously
expressed, LAMP-2C displays a tissue-specific distribution
and is not found in human B cells (D. Zhou and J. S. B.,
unpublished data). Interestingly, overexpression of the
LAMP-2B isoform had no effect on the presentation of
cytoplasmic GAD or SMA yet reductions in total LAMP-2
isoforms perturbed both cytoplasmic and exogenous Ag
presentation by MHC class II. LAMP-2A overexpression
did not change the overall cellular morphology of APC
(D. Zhou and J. S. B., unpublished data), alter the content
of autophagosomes in APC or affect the maturation or
distribution of the lysosomal protease, cathepsin D (16).
These results suggested that while the overexpression of
LAMP-2A in APC enhanced cytoplasmic Ag presentation, it
did not alter the normal cellular processes attributed to
lysosomes. In addition to LAMP-2, the chaperone hsc70 is
essential for the transport of substrates from the cytosol
to lysosomes during CMA. We demonstrated that the
expression of antisense cDNA hsc70 reduced the MHC
class II-restricted presentation of cytoplasmic GAD while
hsc70 overexpression enhanced the presentation of this
Ag (16). To more definitely show that LAMP-2A plays a role
in the transport of cytosolic Ag to the lysosome, we
electroporated a biotinylated version of the GAD peptide
directly into the cytosol of human B cells overexpressing
LAMP-2A and observed both an increase in the relative
abundance of MHC class II:biotin–GAD peptide complexes
within the cells and an enhancement in the GAD-specific
T cell response (16). Thus, our results suggested that
LAMP-2A, possibly in association with hsc70, facilitates
the delivery of epitopes in human B cells from cytoplasmic
Ag to endosomal or lysosomal compartments accessible
to MHC class II molecules, ultimately resulting in the
activation of specific CD4þ T lymphocytes.
Autophagy and the Immune Response
Autophagy is essential for cell survival because this
pathway is responsible for the removal of excessive or
defective subcellular structures such as protein aggre-
gates or damaged organelles and for a cell’s ability to
adapt during periods of physiological stress (23). Thus, it
may not be surprising that autophagy pathways are
induced or altered during infection and immunity, both of
which can involve cell stress responses. Autophagy is
often a component of the immune response to intracellular
pathogens; thus, some microorganisms have evolved
strategies to evade the autophagy pathway. Similarly,
autophagy is believed to play a role not only in tumorigen-
esis but also in tumor suppression and eradication, again
potentially linking this pathway to host defense and
immunity.
Intracellular pathogens
The relationship between autophagy and intracellular
microorganisms such as bacteria and viruses has been
extensively reviewed previously (41); thus, we provide
here a few examples to illustrate this relationship. Bacteria
can enter a cell through phagocytosis, and once inside,
they either escape from the phagosome into the cytosol
prior to fusion with lysosomes or remain within this
compartment and block its fusion with lysosomes (42).
The host cell may initiate autophagy as a defense mech-
anism in order to clear bacteria located in the cytosol or in
isolated vacuoles (43). For example, upon entering the
cytosol from endosomes, Streptococcus pyogenes be-
comes enveloped by autophagosomes and the bacteria
are destroyed upon fusion of the autophagosomes with
lysosomes (44). During infection of macrophages with
Mycobacterium tuberculosis, treatment with IFN-g induces
the small GTPase LRG-47 important in autophagosome
formation, thus facilitating the fusion of pathogen-containing
vacuoles with lysosomes (45). Not surprisingly, bacteria
have evolved strategies to subvert the pathways of auto-
phagy. For example, the cytosolic pathogenShigella flexneri
produces the virulence factor IcsB that inhibits autophagy
(46). Some bacteria such as Legionella pneumophila and
Coxiella burnetii induce the formation of double-membrane
compartments, resembling autophagosomes, for sites of
bacterial replication and then block the maturation of these
compartments to autolysosomes to prevent degradation
(47,48).
Less is known about the role of autophagy in the clearance
of viral infections in host cells. One candidate mechanism
is the activation of the protein kinase PKR by double-
stranded RNA viruses (41); activation of PKR and the
subsequent downstream signaling events have been
shown to induce autophagy during herpesvirus infection.
Recently, Lee et al. showed that autophagy is required
for single-stranded RNA viruses to be detected by a
component of the innate immune system, the Toll-like
receptor 7 (TLR7) (49). In plasmacytoid DC (pDC), auto-
phagy facilitates the transport of viral replication inter-
mediates from the cytosol to lysosomes where TLR7 is
activated. Additionally, autophagy is required for the
production of important mediators of antiviral immunity,
the type 1 interferons, in pDC following infection with
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either single-stranded RNA or double-stranded DNA vir-
uses. Like bacteria, viruses have evolved mechanisms to
utilize autophagy to their advantage. For example, positive-
strand RNA viruses such as polioviruses and coronaviruses
as well as large cytoplasmic DNA viruses such as vaccinia
virus use components of the autophagy pathway to
facilitate viral replication (41,50). These viruses initiate
the formation of double-membrane structures, similar
to autophagosomes, upon which to build their viral repli-
cation complexes. Overall, these examples illustrate how
autophagy and membrane remodeling contribute to the
host cell’s defense against intracellular pathogens and
how these microorganisms have developed strategies to
evade these pathways.
Cancer
In addition to its role in infectious disease, autophagy is
thought to contribute to both cancer development and
tumor eradication. During the early stages of cancer,
autophagy may be suppressed to promote tumor growth,
while in the later stages of oncogenesis, autophagy may
be induced as rapid proliferation of the tumor depletes
critical nutrients (51). Additionally, following chemother-
apy, tumor cells may initiate autophagy as a protective
measure to recycle nutrients or remove damaged cellular
components (51). In contrast, overexpression of autophagy-
specific genes such as beclin-1 inhibits tumor formation in
mice while inactivation of these genes results in significant
tumorigenesis (52). Furthermore, several tumor suppres-
sor genes that facilitate the induction of autophagy are
silenced in cancer cells yet genes such as PI3K that
downregulate autophagy are often activated in tumors
(52). Given the complex nature of the relationship between
autophagy and cancer, more research is needed to further
elucidate the contribution of this pathway to tumorigene-
sis. Additionally, whether changes in the autophagy path-
ways in tumor cells influence immune recognition and
clearance has not yet been explored.
Conclusions
The transport of intracellular substrates from the cytosol to
lysosomes is important not only for the maintenance of
cellular homeostasis but also for more specialized func-
tions in immune cells such as the MHC class II-mediated
presentation of cytoplasmic and nuclear Ag. Multiple
mechanisms of cytosol to lysosome transport, including
but not limited to macroautophagy and CMA, have been
implicated in the delivery of several endogenous Ag to
lysosomes for their eventual presentation by MHC class II
molecules. The discrepancies in the results of these
studies suggest that the type of APC as well as the nature,
half-life and subcellular distribution of endogenous Ag may
influence which transport pathway is utilized. Thus, addi-
tional research is needed to clarify those factors that
ultimately determine the route of Ag delivery. Further
studies are also needed to more clearly define the relation-
ship between the various autophagy pathways and the
immune response to intracellular pathogens and tumors.
Blocking or enhancing these pathways of cytosol to
lysosome transport may alter the MHC class II-mediated
presentation of endogenous Ag to CD4þ T lymphocytes,
thus providing novel therapeutic strategies for the treat-
ment of infectious diseases and cancer.
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